New remote monitoring program aims to help epilepsy patients stick to their meds

NCT ID NCT07507240

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a new care pathway for people with epilepsy who are starting or switching anti-seizure medication. The program combines remote monitoring software with support from a nurse to help patients manage their treatment and detect side effects or seizure changes early. Sixty participants will be split into two groups to compare the new pathway with standard care, focusing on medication adherence and quality of life over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remote monitoring training and nurse therapeutic support
What this could lead to
If successful, this could lead to a better way to support epilepsy patients after medication changes, improving adherence and reducing seizure risk.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to everyone. The program relies on technology access and patient engagement, which may limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cerebral electrophysiology, epilepsy and sleep, Purpan Hospital, Place du Docteur Baylac

    Toulouse, Non, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.